Profile data is unavailable for this security.
About the company
Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). It is designed improve treatment of Non-Hodgkin Lymphoma (NHL) and advanced through clinical development. Additionally, the Company is engaged in the development of its Antibody-Radionuclide-Conjugate (ARC) portfolio to treat various selected cancer indications. It has two subsidiaries, Nordic Nanovector GmbH and Nordic Nanovector Ltd.
- Revenue in NOK (TTM)0.00
- Net income in NOK-450.11m
- LocationNordic Nanovector ASAKjelsasveien 168 BOSLO 0884NorwayNOR
- Phone+47 22183301
- Fax+47 22580007